Background Although lateral pelvic node dissection (LPND) is recommended for rectal
cancer with clinically metastatic lateral pelvic lymph nodes (LPNs), LPNs may respond to …

Abstract Background and Objectives There is no consensus on the safety and indications of
lateral pelvic lymph node dissection (LPND) for patients with clinical lateral pelvic node …

Aim The need or otherwise for lateral pelvic node dissection (LPND) in rectal cancer patients
with clinical lateral pelvic node metastasis (LPNM) after neoadjuvant chemoradiotherapy …

Objective: Lateral pelvic lymph node (LPLN) metastases are an important cause of
preventable local failure in rectal cancer. The aim of this study was to evaluate clinical and …

Objectives We evaluated the relationship between pretreatment clinical parameters and
lateral pelvic node (LPN) recurrence in patients with rectal cancer treated with a combination …

Background Lateral lymph node (LLN) metastasis is a major cause of local recurrence of
advanced rectal cancer. Although there is much controversy between Western and Eastern …

The presence of lateral pelvic lymph nodes (LPLN) in advanced rectal cancer entails
challenges with ongoing debate regarding the role of prophylactic dissection vs …

BACKGROUND: Despite the use of neoadjuvant chemoradiation and total mesorectal
excision for rectal cancer, lateral pelvic lymph node recurrence is still an important problem …

Background The significance of lateral pelvic lymph node (LPLN) metastasis in advanced
low rectal cancer treated with preoperative chemoradiotherapy (CRT) remains unclear. The …

Purpose We aimed to evaluate the surgicopathological outcomes of lateral pelvic lymph
node dissection (LPLD) and long-term oncological outcomes of selective LPLD after …